✦ LIBER ✦

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

✍ Scribed by H. Takei; Suemasu; K. Inoue; T. Saito; K. Okubo; J. Koh; K. Sato; H. Tsuda; M. Kurosumi; T. Tabei

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter phase II trial of neoadjuvan

✍ Hiroyuki Takei; Kimito Suemasu; Kenichi Inoue; Tsuyoshi Saito; Katsuhiko Okubo; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 228 KB

Randomized Phase II Trial Comparing Exem

✍ Kavita Maung; Joyce O'Shaughnessy 📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Exemestane as primary systemic treatment

✍ Brigitte Mlineritsch; Christoph Tausch; Christian Singer; Gero Luschin-Ebengreut 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

First results of a randomized phase III

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB